Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All curcumin studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchCurcuminCurcumin (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Computational Discovery of Mitochondrial Dysfunction Biomarkers in Severe SARS-CoV-2 Infection: Unveiling Their Functions and Facilitating Drug Screening

Zhang et al., Elsevier BV, doi:10.2139/ssrn.4677176
Dec 2023  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Curcumin for COVID-19
15th treatment shown to reduce risk in February 2021
 
*, now known with p = 0.000000046 from 26 studies.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
3,800+ studies for 60+ treatments. c19early.org
In Silico study showing that five mitochondrial dysfunction biomarkers (RECQL4, PYCR1, PIF1, POLQ, and GLDC) can distinguish severe COVID-19 patients from mild cases and uninfected individuals. These biomarkers were associated with dysregulated metabolism and immune cell imbalance in severe patients. Screening 496 natural compounds, the authors predicted curcumin may prevent severe COVID-19 by regulating these biomarkers and protecting mitochondrial function.
In Vitro experiments validated curcumin’s efficacy, demonstrating that it alleviates SARS-CoV-2 spike protein-induced mitochondrial membrane potential damage and oxidative stress.
In Silico studies predict inhibition of SARS-CoV-2 with curcumin or metabolites via binding to the spike Note A, Nag, Moschovou, Kandeil, Singh (B) (and specifically the receptor binding domain Note B, Kant, Srivastava, Eleraky), Mpro Note C, Moschovou, Kandeil, Srivastava, Naderi Beni, Rajagopal, Rampogu, Sekiou, Singh, Winih Kinasih, Thapa, Bahun, Eleraky, RNA-dependent RNA polymerase Note D, Singh (C), Eleraky, ACE2 Note E, Singh (B), Thapa, Alkafaas, nucleocapsid Note F, Hidayah, Suravajhala, and nsp10 Note G, Suravajhala proteins. In Vitro studies demonstrate inhibition of the spike Note A, Mohd Abd Razak (and specifically the receptor binding domain Note B, Goc (B)), Mpro Note C, Bahun, Guijarro-Real, Mohd Abd Razak, Wu, ACE2 Note E, Goc (B), and TMPRSS2 Note H, Goc (B) proteins. In Vitro studies demonstrate efficacy in Calu-3 Note I, Bormann, A549 Note J, Mohd Abd Razak, 293T Note K, Zhang, HEK293-hACE2 Note L, Nittayananta, Wu, 293T/hACE2/TMPRSS2 Note M, Septisetyani, and Vero E6 Note N, Bormann, Eleraky, Kandeil, Leka, Mohd Abd Razak, Nittayananta, Singh, Teshima, Marín-Palma cells. Curcumin is predicted to inhibit the interaction between the SARS-CoV-2 spike protein receptor binding domain and the human ACE2 receptor for the delta and omicron variants Kant, decreases pro-inflammatory cytokines induced by SARS-CoV-2 in peripheral blood mononuclear cells Marín-Palma, and alleviates SARS-CoV-2 spike protein-induced mitochondrial membrane damage and oxidative stress Zhang.
Zhang et al., 31 Dec 2023, preprint, 10 authors. Contact: hanlu1@bmi.ac.cn, zhouwx@bmi.ac.cn.
In Vitro studies are an important part of preclinical research, however results may be very different in vivo.
This PaperCurcuminAll
Computational Discovery of Mitochondrial Dysfunction Biomarkers in Severe SARS-CoV-2 Infection: Facilitating Pytomedicine Screening
Lihui Zhang, Yuehan Li, Wanting Hu, Shengqiao Gao, Yiran Tang, Lei Sun, Ning Jiang, Zhiyong Xiao, Lu Han, Wenxia Zhou
Background: Currently, SARS-CoV-2 has not disappeared and continues to prevail worldwide, with the ongoing risk of mutations and the potential for severe COVID-19. The impairment of monocyte mitochondrial function caused by SARS-CoV-2, leading to a metabolic and immune dysregulation, is a crucial factor in the development of severe COVID-19. The core biomarkers underlying the progression to severe SARS-CoV-2 infection and effective drugs remain unclear. Methods: Firstly, differential gene analysis and gene set enrichment analysis (GSEA) were conducted on monocytes datasets to identify genes and pathways distinguishing severe patients from uninfected individuals. Then, GO and KEGG enrichment analysis on the differentially expressed genes (DEGs) obtained. Take the DEGs and intersect them with the MitoCarta 3.0 gene set to obtain the differentially expressed mitochondrialrelated genes (DE-MRGs). Subsequently, machine learning algorithms were employed to screen potential mitochondrial dysfunction biomarkers for severe COVID-19 based on score values. ROC curves were then plotted to assess the distinguish capability of the biomarkers, followed by validation using two additional independent datasets. Next, the effects of the identified biomarkers on metabolic pathways and immune cells were explored through Gene Set Variation Analysis (GSVA) and CIBERSORT. Finally, potential nature products for severe COVID-19 were screened from the expression profile dataset based on dysregulated mitochondrial-related genes, followed by in vitro experimental validation. Results: There are 1812 DEGs and 17 dysregulated mitochondrial processes between severe COVID-19 patients and uninfected individuals. A total of 77 DE-MRGs were identified, and the potential biomarkers were identified as RECQL4, PYCR1, PIF1, POLQ, and GLDC. In both the training and validation sets, the area under the ROC curve (AUC) for these five biomarkers was greater than 0.9. And they did not show significant changes in mild to moderate patients (P > 0.05), indicating their ability to effectively distinguish severe COVID-19. These biomarkers exhibit a highly significant correlation with the dysregulated metabolic processes (P < 0.05) and immune cell imbalance (P < 0.05) in severe patients, as demonstrated by GSVA and CIBERSORT algorithms. Curcumin has the highest score in the predictive model based on transcriptomic data from 496 natural compounds (P = 0.02; ES = 0.90). Pre-treatment with curcumin for 8 hours has been shown to alleviate mitochondrial membrane potential damage caused by the SARS-CoV-2 S1 protein (P < 0.05) and reduce elevated levels of reactive oxygen species (ROS) (P < 0.01). Conclusions: The results of this study indicate a significant correlation between severe SARS-CoV-2 infection and mitochondrial dysfunction. The proposed five mitochondrial dysfunction biomarkers identified in this study are associated with the disease progression, metabolic and immune changes..
Author contributions W.Z., L.H. and L.Z. conceived and designed the experiments. L.Z., Y.L., W.H. and S.G. collected the original data and finished the analysis. L.Z., Y.T., L.S. and S.X. performed the experiments. L.Z. and L.H drafted the initial manuscript. W.Z., N.J. and Z.X. helped revise the manuscript. All authors have read and approved the final manuscript. This preprint research paper has not been peer reviewed. Electronic copy available at: https://ssrn.com/abstract=4677176 P r e p r i n t n o t p e e r r e v i e w e d This preprint research paper has not been peer reviewed. Electronic copy available at: https://ssrn.com/abstract=4677176 P r e p r i n t n o t p e e r r e v i e w e d Competing interests
References
Ahn, Lee, Kim, Random-forest model for drug-target interaction prediction via Kullbeck-Leibler divergence, J. Cheminformatics
Anderson, Maes, Mitochondria and immunity in chronic fatigue syndrome, Prog. Neuropsychopharmacol. Biol. Psychiatry
Arunachalam, Wimmers, Mok, Perera, Scott et al., Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans, Science
Bardou, Mariette, Escudié, Djemiel, Klopp, jvenn: an interactive Venn diagram viewer, BMC Bioinform
Barrett, Wilhite, Ledoux, Evangelista, Kim et al., NCBI GEO: archive for functional genomics data sets--update, Nucleic Acids Res
Bogner, Stiers, Tanner, Structure, biochemistry, and gene expression patterns of the proline biosynthetic enzyme pyrroline-5-carboxylate reductase (PYCR), an emerging cancer therapy target, Amino acids
Bormann, Alt, Schipper, Van De Sand, Le-Trilling et al., Turmeric Root and Its Bioactive Ingredient Curcumin Effectively Neutralize SARS-CoV-2 In Vitro, Viruses
Cheong, Ravishankar, Sharma, Parkhurst, Grassmann et al., Epigenetic memory of coronavirus infection in innate immune cells and their progenitors, Cell
Chi, Nie, Peng, Yang, Yang et al., RecQL4 cytoplasmic localization: implications in mitochondrial DNA oxidative damage repair, Int. J. Biochem
Church, Watkins, The transformation in biomarker detection and management of drug-induced liver injury, Liver Int
Codo, Davanzo, Monteiro, De Souza, Muraro et al., Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis, Cell Metab
Colombo, Wu, Ottolina, Fossali, Montomoli et al., Failing categorization of severe COVID-19 ARDS into ventilatory subphenotypes studied via the clinical-histopathologic relationship, RESP MED
Cosgun, Bilirubin levels as an independent predictor of myocarditis in patients with COVID-19, Egypt Heart J
Croteau, Rossi, Canugovi, Tian, Sykora et al., RECQL4 localizes to mitochondria and preserves mitochondrial DNA integrity, Aging cell
Dennis, Jr, Sherman, Hosack, Yang et al., DAVID: Database for Annotation, Visualization, and Integrated Discovery, Genome Biol
Drucker, Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning, Cell Metab
Duan, Ma, Zeng, Chen, Hou et al., SARS-CoV-2 Achieves Immune Escape by Destroying Mitochondrial Quality: Comprehensive Analysis of the Cellular Landscapes of Lung and Blood Specimens From Patients With COVID-19, Front. Immunol
Engebretsen, Bohlin, Statistical predictions with glmnet, Clin Epigenetics
Gibellini, De Biasi, Paolini, Borella, Boraldi et al., Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia, EMBO Mol Med
Gibellini, De Biasi, Paolini, Borella, Boraldi et al., Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia, EMBO Mol Med
Giroux, Ding, Mcclain, Burke, Petzold et al., Differential chromatin accessibility in peripheral blood mononuclear cells underlies COVID-19 disease severity prior to seroconversion, Sci Rep
Guarnieri, Dybas, Fazelinia, Kim, Frere et al., Core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts, Sci Transl Med
Gürsoy, Sürmeli, Alkan, Satıcı, Altunok et al., Cytokine storm in severe COVID-19 pneumonia, J. Med. Virol
Hu, Huang, Yin, The cytokine storm and COVID-19, J. Med. Virol
Huang, Cai, Pacheco, Narrandes, Wang et al., Applications of Support Vector Machine (SVM) Learning in Cancer Genomics, Cancer Genomics Proteomics
Hänzelmann, Castelo, Guinney, GSVA: gene set variation analysis for microarray and RNA-seq data, BMC Bioinf
Iskar, Campillos, Kuhn, Jensen, Van Noort et al., Drug-induced regulation of target expression, PLOS COMPUT BIOL
Junqueira, Crespo, Ranjbar, De Lacerda, Lewandrowski et al., FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation, Nature
Kanehisa, Goto, KEGG: kyoto encyclopedia of genes and genomes, Nucleic Acids Res
Kumari, Hussain, De, Chandra, Modi et al., Mitochondrial functions of RECQL4 are required for the prevention of aerobic glycolysis-dependent cell invasion, J. Cell. Sci
Lahaye, Stahl, Thines-Sempoux, Foury, PIF1: a DNA helicase in yeast mitochondria, EMBO J
Li, Bie, Song, Liu, Luo, PYCR, a key enzyme in proline metabolism, functions in tumorigenesis, Amino acids
Li, Hook, Ding, Chung, Mettlen et al., Neutrophil metabolomics in severe COVID-19 reveal GAPDH as a suppressor of neutrophil extracellular trap formation, Nat Commun
Li, Wang, Liu, Luo, Lei et al., Antiviral and virucidal effects of curcumin on transmissible gastroenteritis virus in vitro, J. Gen. Virol
Lévy, Wiedemann, Hejblum, Durand, Lefebvre et al., French COVID cohort study group., 2021. CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death, iScience
Marín-Palma, Tabares-Guevara, Zapata-Cardona, Flórez-Álvarez, Yepes et al., Curcumin Inhibits In Vitro SARS-CoV-2 Infection In Vero E6 Cells through Multiple Antiviral Mechanisms, Molecules
Mcgill, Sharpe, Williams, Taha, Curry et al., The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation, J Clin Invest
Montefusco, Ben Nasr, D'addio, Loretelli, Rossi et al., Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection, Nat. Metab
Newman, Liu, Green, Gentles, Feng et al., Robust enumeration of cell subsets from tissue expression profiles, Nat. Methods
Overmyer, Shishkova, Miller, Balnis, Bernstein et al., Large-Scale Multi-omic Analysis of COVID-19 Severity, Cell Syst
Rath, Sharma, Gupta, Ast, Chan et al., MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations, Nucleic Acids Res
Ren, Wen, Fan, Hou, Su et al., COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas, Cell
Ritchie, Phipson, Wu, Hu, Law et al., limma powers differential expression analyses for RNA-sequencing and microarray studies, Nucleic Acids Res
Robin, Turck, Hainard, Tiberti, Lisacek et al., pROC: an open-source package for R and S+ to analyze and compare ROC curves, BMC Bioinf
Shannon, Markiel, Ozier, Baliga, Wang et al., Cytoscape: a software environment for integrated models of biomolecular interaction networks, Genome Res
Spinelli, Haigis, The multifaceted contributions of mitochondria to cellular metabolism, Nat. Cell Biol
Subramanian, Tamayo, Mootha, Mukherjee, Ebert et al., Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles, Proc. Natl. Acad. Sci. U.S.A
Szklarczyk, Kirsch, Koutrouli, Nastou, Mehryary et al., The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest, Nucleic Acids Res
Tian, Zhang, Yuan, Wang, Lv et al., Exploring pharmacological active ingredients of traditional Chinese medicine by pharmacotranscriptomic map in ITCM, Brief. Bioinformatics
Van Kempen, Deixler, SARS-CoV-2: influence of phosphate and magnesium, moderated by vitamin D, on energy (ATP) metabolism and on severity of COVID-19, Am J Physiol Endocrinol Metab
Wang, Zhang, Zhao, Dong, Wu et al., Low high-density lipoprotein level is correlated with the severity of COVID-19 patients: an observational study, Lipids Health Dis
Westbrook, Bridges, Roberts, Escribano-Gonzalez, Eales et al., Proline synthesis through PYCR1 is required to support cancer cell proliferation and survival in oxygen-limiting conditions, Cell Rep
Wood, Doublié, DNA polymerase θ (POLQ), double-strand break repair, and cancer, DNA Repair (Amst.)
Wu, Chen, Xia, Wang, Tan et al., Transcriptional and proteomic insights into the host response in fatal COVID-19 cases, Proc Natl Acad Sci U S A
Yang, Wu, Meng, Wang, Younis et al., SARS-CoV-2 membrane protein causes the mitochondrial apoptosis and pulmonary edema via targeting BOK, Cell Death Differ
Yu, Wang, Han, He, clusterProfiler: an R package for comparing biological themes among gene clusters, OMICS
Zhou, Chi, Lv, Wang, Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19), Diabetes Metab. Res. Rev
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit